4.7 Article

A Single Nucleotide Polymorphism in STK11 Influences Insulin Sensitivity and Metformin Efficacy in Hyperinsulinemic Girls With Androgen Excess

Related references

Note: Only part of the references are listed.
Review Medicine, Research & Experimental

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease

Aaron K. F. Wong et al.

CLINICAL SCIENCE (2009)

Article Endocrinology & Metabolism

Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche

Lourdes Ibanez et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Article Endocrinology & Metabolism

Ovulatory response to treatment of polycystic ovary syndrome is associated with a polymorphism in the STK11 gene

Richard S. Legro et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)

Review Cell Biology

New roles for the LKB1→AMPK pathway

DG Hardie

CURRENT OPINION IN CELL BIOLOGY (2005)

Article Biochemistry & Molecular Biology

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

JM Lizcano et al.

EMBO JOURNAL (2004)

Article Endocrinology & Metabolism

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain

M Asunción et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)